Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive

13 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Record	Firm	Date
Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia (NCT04526795)	M.D. Anderson Cancer Center	2021-04-09
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (NCT04681105)	City of Hope Medical Center	2020-11-18
Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia (NCT04188405)	M.D. Anderson Cancer Center	2020-05-17
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial (NCT03878524)	OHSU Knight Cancer Institute	2020-04-01
Ex Vivo Drug Sensitivity Testing and Mutation Profiling (NCT03860376)	Florida International University	2019-02-21
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy (NCT03630991)	M.D. Anderson Cancer Center	2018-10-11
Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia (NCT03576547)	M.D. Anderson Cancer Center	2018-06-26
EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia (NCT03519984)	University of Southern California	2018-05-09
Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT (NCT02728700)	Stanford University	2016-02-01
Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML (NCT02311998)	M.D. Anderson Cancer Center	2015-04-16
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia (NCT02115295)	M.D. Anderson Cancer Center	2014-05-19
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant (NCT01231412)	Fred Hutchinson Cancer Center	2010-11-01

Track Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive automatically

Every clearance here is in the API, with alerts when new ones post.